Medication-related problems (MRPs), including adverse drug reactions, inappropriate prescribing, and drug interactions, constitute a significant burden on healthcare systems globally, impacting patient safety, clinical outcomes, and healthcare costs. The complexity of modern pharmacotherapy, particularly in patients with polypharmacy and comorbidities, necessitates specialized expertise in medication management. Clinical Pharmacology Consultation (CPC) provides in-depth pharmacological assessment and evidence-based recommendations to optimize drug therapy. This article presents a single-center retrospective audit evaluating the impact and utility of CPCs in improving patient care. We analyzed the types of medication-related issues addressed, the recommendations provided by clinical pharmacologists, and their acceptance rates and documented effects on patient management. Our findings demonstrate that CPCs play a crucial role in identifying and resolving complex MRPs, leading to improved medication safety, enhanced therapeutic efficacy, and better overall patient care. These results underscore the significant value of integrating clinical pharmacology expertise into routine clinical practice, especially for challenging medication-related scenarios.

Clinical pharmacology, patient outcomes, medication optimization

Dollery CT. Clinical pharmacology – The first 75 years and a view of the future. Br J Clin Pharmacol 2006;61:650–65.

Alsultan A, Alghamdi WA, Alghamdi J, Alharbi AF, Aljutayli A, Albassam A, et al. Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia. Saudi Pharm J 2020;28:1217–27.

Thürmann PA. Clinical pharmacology in everyday clinical care. Eur J Clin Pharmacol 2013;69:89–93.

Greiver M, Dahrouge S, O’Brien P, Manca D, Lussier MT, Wang J, et al. Improving care for elderly patients living with polypharmacy: Protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada. Implement Sci 2019;14:55.

Pharmacy AC of C. Standards of practice for clinical pharmacists. Pharmacother J Hum Pharmacol Drug Ther 2014;34:794–7.

Ronan S, Shannon N, Cooke K, McKeon T, Walsh EK, Kearney A, et al. The role of the clinical pharmacist in an Irish University Teaching Hospital: A mixed-methods study. Pharmacy (Basel, Switzerland) 2020;8:14.

Nowaskie DZ, Fogel RS, Fogel JM. Impact on patient satisfaction and importance of medical intake and office staff in a multidisciplinary, one-stop shop transgender program in Indianapolis, Indiana. J Multidiscip Healthc 2019;12:665–73.

Al-Abri R, Al-Balushi A. Patient satisfaction survey as a tool towards quality improvement. Oman Med J 2014;29:3–7.

Nabergoj Makovec U, Tomsic T, Kos M, Stegne Ignjatovic T, Poplas Susic A. Pharmacist-led clinical medication review service in primary care: The perspective of general practitioners. BMC Prim Care 2023;24:6.

Gallagher P, O’Mahony D. STOPP (screening tool of older persons’ potentially inappropriate prescriptions): Application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008;37:673–9.

Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006;54:1516–23.

Ulley J, Harrop D, Ali A, Alton S, Fowler Davis S. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: A systematic review. BMC Geriatr 2019;19:15.

Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: The EMPOWER cluster randomized trial. JAMA Intern Med 2014;174:890–8.

Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: Addressing polypharmacy. Arch Intern Med 2010;170:1648–54.

Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010;170:1648–54.

World Health Organization. Medication without Harm. Geneva: World Health Organization. Available from: https://www.who.int/initiatives/medication-without-harm.

Samajdar SS, Tripathi SK. Clinical pharmacological reconciliation, review, and feedback in ensuring patient safety: A commentary. J Clin Pharmacol 2023;63:1074–5.

Das S, Samajdar SS, Mukherjee S, Sarkar S, Sen S, Pathak A, et al. Ten clinical pharmacological interventions in routine care to ensure better treatment outcomes. Int. J. Pharm. Pract. 2023;31:444–6.

Samajdar SS, Mukherjee S, Sarkar S, Sen S, Tripathi SK, Joshi SR. Clinical pharmacological consultation in optimizing diabetic patient care: A cross-sectional observational study. Bengal Physician J 2023;10:6–8.

Kshirsagar NA, Bachhav SS, Kulkarni LA, Vijaykumar. Clinical pharmacology training in India: Status and need. Indian J Pharmacol 2013;45:429–33.

Wallerstedt SM, Kindblom JM, Nylén K, Samuelsson O, Strandell A. Medication reviews for nursing home residents to reduce mortality and hospitalization: Systematic review and meta-analysis. Br J Clin Pharmacol 2014;78:488–97.

Rothberg MB, Pekow PS, Liu F, Korc-Grodzicki B, Brennan MJ, Bellantonio S, et al. Potentially inappropriate medication use in hospitalized elders. J Hosp Med 2008;3:91–102.

Stuijt CCM, Franssen EJF, Egberts ACG, Hudson SA. Appropriateness of prescribing among elderly patients in a Dutch residential home: Observational study of outcomes after a pharmacist-led medication review. Drugs Aging 2008;25:947–54.